Definitive Contract 75N93019C00064
Award Date
9/30/19
Potential Completion Date
9/29/25
Potential Value
$6.3M
Federal Agency
National Institute of Allergy and Infectious Diseases
Ultimate Awardee
Not listed
NAICS Category
541512 - Computer Systems Design Services
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Worcester, MA 01655, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
13
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH) has awarded a $6,000,000, 5-year cost-reimbursement contract to the University of Massachusetts Medical School (UMMS) for research on T cell immune epitopes associated with infectious diseases, autoimmune diseases, and transplant outcomes. The contract, which is not set-aside, is part of NIAID's effort to support multi-disciplinary teams focused on large-scale discovery and validation...
This is a $4,495,633 definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to the La Jolla Institute for Immunology, a non-profit research institute, for "LARGE SCALE T CELL EPITOPE DISCOVERY". The contract has no set-aside designation. The contract involves T cell and B cell immunology research, including epitope identification, vaccine development, and studies on the immune mechanisms underlying infectious diseases, allergies, autoimmune...
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to The University of Texas Health Science Center at San Antonio (UTHSCSA). The $1,872,050.25 contract is for THERAPEUTICS TESTING IN MURINE MODELS OF FUNGAL INFECTIONS such as aspergillosis, candidiasis, and mucormycosis. This contract is a delivery order issued under NIAID's larger "Animal Models of Infectious Diseases 2010-2017"...
This is a definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian federal agency, to the Regents of the University of Michigan (UM) to provide research and development services for the project "IDENTIFYING TARGETS FOR THERAPEUTICS USING PROTEOMICS TECHNOLOGY". The contract was awarded on June 30, 2004 with a ceiling value of $5,968,614.00 and a completion date of June 29, 2009. The contract does not have a set-aside designation. As...
This definitive federal contract was awarded by the Department of Health and Human Services' National Institute of Allergy and Infectious Diseases to the La Jolla Institute for Immunology, a non-profit research organization, to conduct large-scale T cell epitope discovery research. The contract has a potential value of $4,499,760.00 and is not set aside for any specific business type. The contract involves multiple subcontractors to assist with the research, including the Universidad Peruana...
This firm fixed price delivery order contract was awarded to the University of Texas Health Science Center at San Antonio (UTHSCSA) by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The $1,589,216 award is for therapeutics testing in murine models of fungal infections under Task Order A86 of NIAID's Preclinical Models of Infectious Diseases 2017-2024 contract. As a prime contractor under this $146.3 million indefinite...
This is a $29,057,109.85 definitive federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the University of Maryland, Baltimore (UMB) for biomedical research and development. The contract has no set-aside designation. UMB, a major public research university, is the prime contractor and frequently receives federal contracts and grants for its expertise in areas such as medicine, nursing,...
This is a delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH), a civilian agency. The contract was awarded to the University of Maryland, Baltimore (UMB) on April 10, 2015 and has a ceiling value of $882,112.66. It is a task order under the Vaccine and Treatment Evaluation Units (VTEU) Indefinite Delivery Vehicle (IDV), which allows NIAID to place orders for medical research and services...
This is a task order award under the National Institute of Allergy and Infectious Diseases (NIAID) Preclinical Models of Infectious Diseases 2017-2024 indefinite delivery contract, which has a ceiling value of $844,610.97. The prime contractor is The University of Texas Health Science Center at San Antonio (UTHSCSA), a state-controlled institution of higher education that serves as a hub for biomedical research, particularly focused on Hispanic, military, and veteran health issues. This $200,594...
This is a non-severable definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to the University of Montana for a base period of three years from September 30, 2018, to September 29, 2021, with a total potential value of $18,280,011.02 and an ultimate completion date of July 14, 2025. The contract is a cost-no-fee arrangement and does not have a set-aside designation. The...